Dr Andrea Pavesi is a young investigator at the institute of molecular and cell biology (IMCB A*Star). His group is currently focused on developing and utilizing microfluidic platforms mainly for, but not limited to, cancer research by creating multicellular models with conditions and stimulations that play a fundamental role in specific human tissues. Andrea is also a co-founding member of a Singapore-based start-up AIM Biotech, which recently obtained in December 2020 a series A investment round. AIM Biotech is also integrated into Andrea’s lab as a joint service laboratory. Andrea completed his postdoc at the Singapore MIT Alliance (SMART) under Prof Roger Kamm’s supervision, and before that, he was awarded with the Interpolitechnic PdD fellowship (Biomedical and Biomechanical engineering). Andrea also attended the ESSEC business school with a master’s in health industries management.